Litt etter litt kommer det frem hva som er årsaken til at AstraZencha reduserer antallet vaksinedoser til EU (og dermed Norge), mens antallet vaksiner til bl.a. Storbritannia går som planlagt:
EU signerte kontrakten mye senere (3 måneder) enn det britene gjorde, noe som har medført at de har hatt kortere tid på å fjerne problemer i produksjonslinjen for vaksinene som skal til EU.
"Anyway, we didn’t commit with the EU, by the way. It’s not a commitment we have to Europe: it’s a best effort, we said we are going to make our best effort. The reason why we said that is because Europe at the time wanted to be supplied more or less at the same time as the UK, even though the contract was signed three months later. So we said, „Ok, we’re going to do our best, we’re going to try, but we cannot commit contractually because we are three months behind UK“. We knew it was a super stretch goal and we know it’s a big issue, this pandemic. But our contract is not a contractual commitment. It’s a best effort. Basically, we said we’re going to try our best, but we can’t guarantee we’re going to succeed. In fact, getting there, we are a little bit delayed."
Det blir mer og mer klart at Norge burde håndtert innkjøp av vaksiner på egenhånd.